Metabolite toxicity determination

Only one naturally occurring azide has been reported to date. 6-Azidotetrazolo[5,l-u]phthalazine (6) was isolated, by chloroform extraction and subsequent chromatographic purification, from unialgal cultures of Gymnodinium breve (Ptychodiscus brevis), a dinoflagellate responsible for the production of toxic red tides along the Gulf Coast of Florida [16]. The structure of this extraordinary secondary metabolite was determined by... 

Drugs and xenobiotics often are metabolized by several different phase I and phase II pathways to give a number of mctabolitc.s. The relative amount of any particular metabolite is determined by the concentration and activity of the en-7.yme(s) responsible for the biotransformation. The rate of metabolism of a drug is particularly important for its pharmacological action as well as its toxicity. For example, if the rate of metabolism of a drug is decrea.sed. this generally... 

Metabolism of a chemical plays an essential role in the toxicity evaluation of a chemical. It will usually result in the conversion to a more water-soluble metabolite, enhancing the excretion ratio and shortening the half-life of the chemical in vitro. However, biotransformation may also result in a metabolite with a higher reactivity, thus increasing the toxic potential of exposure to the chemical. Because in many cases in vitro systems do not account for this bioactivation, this factor is considered an important drawback of in vitro toxicity determinations [18]. 

The present approach for metabolism studies of pesticides and animal health drugs is to administer the compound to plants or animals in a manner that represents normal use conditions in the field. This approach prevents successful identification of metabolites and restrains what should be the proper way to identify metabolites. Little attempt is made to correlate metabolic results and toxicity. The chemist already knows that insoluble, unidentifiable residues will most likely occur from multiple dosing and that the problem of identifying metabolites and determining their toxicity is still present. 

Differences in phthalate structure determine how they are metabolized and their toxic effects. MBuP and MBzP, metabolites of DBP and BBzP, have been identified as active metabolites toxic to reproductive endpoints, including sperm concentration in adult males (Hauser et al. 2006). Direct measures of parent phthalates or phthalate monoester metabolites in blood are difficult to interpret because of the high likelihood of contamination from sampling or from lab materials given that esterase activity after sample collection can generate monoester metabolites in samples contaminated after collection (Calafat et al. 2013). 

For convenience, the processes identified in Figure 2.1 can be separated into two distinct categories toxicokinetics and toxicodynamics. Toxicokinetics covers uptake, distribution, metabolism, and excretion processes that determine how much of the toxic form of the chemical (parent compound or active metabolite) will reach the site of action. Toxicodynamics is concerned with the interaction with the sites of action, leading to the expression of toxic effects. The interplay of the processes of toxicokinetics and toxicodynamics determines toxicity. The more the toxic form of the chemical that reaches the site of action, and the greater the sensitivity of the site of action to the chemical, the more toxic it will be. In the following text, toxicokinetics and toxicodynamics will be dealt with separately. 

Metabolomics studies the entire metabolism of an organism. It is possible to consider characterising the complex pattern of cellular proteins and metabolites that are excreted in urine. Pattern recognition techniques of nuclear magnetic resonance spectra have been applied to determine the dose-response using certain classical liver and kidney toxicants (Robertson et al, 2000). This could well provide a signature of the functional state of the kidney, and perturbations in the pattern as a result of exposure to a chemical could be observed. But first it would be necessary to understand how compounds with known effects on the kidney affect these processes. 

Ethylenethiourea (ETU) is a toxic decomposition product/metabolite of alky-lenebis(dithiocarbamates). This compound could be generated during processing of treated crops at elevated temperature. Different chromatographic methods to determine the residue levels of ETU have been published. After extraction with methanol, clean-up on a Gas-Chrom S/alumina column and derivatization (alkylation) with bro-mobutane, ETU residues can be determined by GC with a flame photometric detector in the sulfur mode. Alternatively, ETU residues can also be determined by an HPLC method with UV detection at 240 nm or by liquid chromatography/mass spectrometry (LC/MS) or liquid chromatography/tandem mass spectrometry (LC/MS/MS) (molecular ion m/z 103). ... 

An additional determinate of 5-FU toxicity, regardless of the method of administration, is related to its catabolism and phar-macogenomic factors. Dihydropyrimidine dehydrogenase (DPD) is the main enzyme responsible for the catabolism of 5-FU to inactive metabolites.37 A pharmacogenetic disorder has been identified in which patients have a complete or near-complete... 

No studies were located regarding toxicokinetic data in humans. Limited information is available regarding the toxicokinetic differences among animal species. Rats, mice, mink, and dogs showed rapid absorption, wide distribution, and over 90% urinary excretion of diisopropyl methylphosphonate or its metabolites. However, the rates of absorption and patterns of distribution varied (Hart 1976 Weiss et al. 1994). The mechanism of toxicity is also undetermined. From the limited data available, it is not possible to determine the degree of correlation between humans and animals. 

Absorption, Distribution, Metabolism, and Excretion. There are no data available on the absorption, distribution, metabolism, or excretion of diisopropyl methylphosphonate in humans. Limited animal data suggest that diisopropyl methylphosphonate is absorbed following oral and dermal exposure. Fat tissues do not appear to concentrate diisopropyl methylphosphonate or its metabolites to any significant extent. Nearly complete metabolism of diisopropyl methylphosphonate can be inferred based on the identification and quantification of its urinary metabolites however, at high doses the metabolism of diisopropyl methylphosphonate appears to be saturated. Animal studies have indicated that the urine is the principal excretory route for removal of diisopropyl methylphosphonate after oral and dermal administration. Because in most of the animal toxicity studies administration of diisopropyl methylphosphonate is in food, a pharmacokinetic study with the compound in food would be especially useful. It could help determine if the metabolism of diisopropyl methylphosphonate becomes saturated when given in the diet and if the levels of saturation are similar to those that result in significant adverse effects. 

Bioremediation also has its limitations. Some chemicals are not amenable to biodegradation, for instance, heavy metals, radionuclides, and some chlorinated compounds. In some cases, the microbial metabolism of the contaminants may produce toxic metabolites. Bioremediation is a scientifically intensive procedure that must be tailored to site-specific conditions, and usually requires treatability studies to be conducted on a small scale before the actual cleanup of a site.13 The treatability procedure is important, as it establishes the extent of degradation and evaluates the potential use of a selected microorganism for bioremediation. A precise estimate on vessel size or area involved, speed of reaction, and economics can therefore be determined at the laboratory stage. 

---